Search

401. Perioperative medication errors: uncovering risk from behind the drapes

Author(s):

Cierniak, Kayla, author
Gaunt, Michael J., author
Grissinger, Matthew, author

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, December 2018

Subject(s):

Medication Errors -- prevention & control
Medication Errors -- statistics & numerical data
Pennsylvania
United States

402. Bridging silos: Part II : DI, SSI, Medicare, and Medicaid issues and initiatives

Author(s):

Matherlee, Karen.

Publication:

Washington, D.C. : National Health Policy Forum, [2003]

Subject(s):

Insurance, Disability -- economics
Medicaid -- economics
Medicare -- economics
Public Assistance -- economics
United States

403. Necessary but not sufficient?: physician volunteerism and the health care safety net

Author(s):

Salinsky, Eileen.

Publication:

Washington, D.C. : National Health Policy Forum, [2004]

Subject(s):

Delivery of Health Care -- economics
Hospital Volunteers -- economics
Physicians
Health Planning -- organization & administration
United States

404. The U.S. health workforce: definitions, dollars, and dilemmas

Author(s):

Matherlee, Karen.

Publication:

Washington, D.C. : National Health Policy Forum, [2003]

Subject(s):

Health Personnel -- statistics & numerical data
Health Workforce -- statistics & numerical data
Office Visits -- statistics & numerical data
Salaries and Fringe Benefits -- economics
United States

405. Fundamentals of the prescription drug market

Author(s):

Peters, Christie Provost.

Publication:

Washington, D.C. : National Health Policy Forum, [2004]

Subject(s):

Drug Industry -- economics
United States

406. A report from the Forum session: implementing the Medicare prescription drug benefit : continuing challenges for states

Author(s):

Partridge, Lee, (Consultant)

Publication:

Washington, DC : National Health Policy Forum, [2005]

Subject(s):

Medicare
Insurance, Pharmaceutical Services
United States
United States.

407. Caring for "Ryan White": the fundamentals of HIV/AIDS treatment policy

Author(s):

Taylor, Jessamy.

Publication:

Washington, DC : National Health Policy Forum, [2005]

Subject(s):

HIV Infections -- epidemiology
Acquired Immunodeficiency Syndrome -- epidemiology
HIV Infections -- therapy
Acquired Immunodeficiency Syndrome -- therapy
Health Policy
United States -- epidemiology
United States.

408. The vaccine industry: does it need a shot in the arm?

Publication:

Washington, D.C. : National Health Policy Forum, [2006]

Subject(s):

Drug Industry -- economics
Vaccines -- supply & distribution
United States

409. Health information technology adoption among health centers: a digital divide in the making?

Publication:

Washington, D.C. : George Washington University, [2007]

Subject(s):

Community Health Centers
Diffusion of Innovation
Medical Informatics
United States

410. Medicare and mental health: the fundamentals

Publication:

Washington, D.C. : George Washington University, [2006]

Subject(s):

Insurance Coverage
Medicare -- economics
Mental Disorders -- economics
Mental Health -- statistics & numerical data
United States
Medicare Payment Advisory Commission (U.S.)

411. Relative value units (RVUs): the basics

Publication:

Washington, D.C. : George Washington University, [2009]

Subject(s):

Medicare -- economics
Relative Value Scales
United States
Centers for Medicare & Medicaid Services (U.S.)

412. The prescription drug safety net: access to pharmaceuticals for the uninsured

Publication:

Washington, D.C. : George Washington University, [2007]

Subject(s):

Health Services Accessibility
Medical Assistance
Pharmaceutical Services
Uncompensated Care
United States
United States. Health Resources and Services Administration

413. Medicaid disproportionate share hospital (DSH) payments: the basics

Publication:

Washington, D.C. : George Washington University, [2009]

Subject(s):

Medicaid -- economics
Medicaid -- legislation & jurisprudence
Reimbursement, Disproportionate Share -- economics
Reimbursement, Disproportionate Share -- legislation & jurisprudence
United States

414. The Medicare drug benefit coverage gap: the basics

Publication:

Washington, D.C. : George Washington University, [2011]

Subject(s):

Insurance Coverage -- economics
Insurance Coverage -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
United States

415. National spending for long-term services and supports (LTSS): the basics

Publication:

Washington, D.C. : George Washington University, [2011]

Subject(s):

Health Expenditures -- statistics & numerical data
Long-Term Care -- economics
Long-Term Care -- statistics & numerical data
United States

416. The fundamentals of health savings accounts and high-deductible health plans

Publication:

Washington, D.C. : George Washington University, [2007]

Subject(s):

Cost Sharing
Deductibles and Coinsurance
Insurance, Health
Medical Savings Accounts -- organization & administration
United States

417. Display devices for diagnostic radiology: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, October 2, 2017

Subject(s):

Data Display -- standards
Image Processing, Computer-Assisted -- standards
Radiology Information Systems -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

418. The prohibition of distributing free samples of tobacco products

Publication:

Silver Spring, MD : Center for Tobacco Products, Food and Drug Administration, October 2017

Subject(s):

Commerce -- standards
Government Regulation
Tobacco Products -- supply & distribution
Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

419. De novo classification process (evaluation of automatic class III designation): guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, October 30, 2017

Subject(s):

Classification
Device Approval -- standards
Equipment and Supplies -- classification
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

420. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, November 17, 2017

Subject(s):

Equipment and Supplies -- standards
Equipment Reuse -- standards
Product Labeling -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

421. Deciding when to submit a 510(k) for a software change to an existing device: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, October 25, 2017

Subject(s):

Device Approval -- standards
Software -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

422. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, December 2017

Subject(s):

Autografts -- standards
Biological Products -- standards
Biological Products -- therapeutic use
Tissue Transplantation -- standards
Transplantation, Autologous
Transplantation, Homologous
Transplants -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

423. Pediatric information for x-ray imaging device premarket notifications: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, November 28, 2017

Subject(s):

Equipment Safety -- standards
Product Labeling -- standards
Radiation Dosage
Radiation Exposure -- adverse effects
Radiation Exposure -- standards
Radiography -- adverse effects
Radiography -- instrumentation
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

424. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, December 5, 2017

Subject(s):

Device Approval
Equipment and Supplies
Insurance Coverage
Medicare -- economics
Therapies, Investigational
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
Centers for Medicare & Medicaid Services (U.S.)

425. Deciding when to submit a 510(k) for a change to an existing device: guidance for Industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, October 25, 2017

Subject(s):

Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

426. Compounded drug products that are essentially copies of a commercially available drug product under Section 503A of the Federal Food, Drug, and Cosmetic Act

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, January 2018

Subject(s):

Drug Compounding -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

427. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents

Author(s):

Doshi, Jalpa A., author
Li, Bengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Armstrong, Katrina A., author

Publication:

Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018

Subject(s):

Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Drug Costs
Financing, Personal -- statistics & numerical data
Assessment of Medication Adherence
United States

428. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2017

Subject(s):

Communication
Drug Industry
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

429. Obesity in America: a growing threat

Author(s):

Salinsky, Eileen.

Publication:

Washington, D.C. : George Washington University, National Health Policy Forum, [2003]

Subject(s):

Obesity -- prevention & control
Health Promotion
Obesity -- economics
Obesity -- etiology
United States

430. Health insurance coverage for small employers

Author(s):

Gencarelli, Dawn M.

Publication:

Washington, DC : National Health Policy Forum, [2005]

Subject(s):

Health Benefit Plans, Employee -- economics
Employer Health Costs -- trends
Health Care Reform
United States

431. Shaping public programs through Medicare, Medicaid, and SCHIP waivers: the fundamentals

Author(s):

Shirk, Cynthia.

Publication:

Washington, D.C. : National Health Policy Forum, [2003]

Subject(s):

Insurance, Health -- economics
Medicaid -- economics
Medicare -- economics
United States

432. Health savings accounts: the fundamentals

Author(s):

Fuchs, Beth C. (Beth Carol)

Publication:

Washington, D.C. : National Health Policy Forum, [2005]

Subject(s):

Medical Savings Accounts
Insurance, Health
United States

433. Value-based coverage policy in the United States and the United Kingdom: different paths to a common goal

Publication:

Washington, D.C. : George Washington University, [2006]

Subject(s):

Cost-Benefit Analysis
Evidence-Based Medicine
Insurance Coverage -- economics
Technology Assessment, Biomedical
United Kingdom
United States
United States. Agency for Healthcare Research and Quality
Blue Cross Association.
Blue Shield Association.
Centers for Medicare & Medicaid Services (U.S.)
National Institute for Health and Clinical Excellence (Great Britain)

434. The Medicare drug benefit (Part D): the basics

Publication:

Washington, DC : George Washington University, January 4, 2016

Subject(s):

Insurance Benefits
Insurance, Pharmaceutical Services
Medicare Part D -- organization & administration
United States

435. Advancement of emerging technology applications for pharmaceutical innovation and modernization

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2017

Subject(s):

Biomedical Technology -- standards
Drug Industry -- standards
Inventions
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

436. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, October 2, 2017

Subject(s):

Clinical Laboratory Techniques
Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

437. Recommended statement for over-the-counter aspirin-containing drug products labeled with cardiovascular related imagery

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2017

Subject(s):

Aspirin
Drug Labeling
Drug Packaging
Nonprescription Drugs
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

438. Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017

Subject(s):

Blood Donors
Chagas Disease -- blood
Chagas Disease -- transmission
Disease Transmission, Infectious -- prevention & control
Donor Selection
Serologic Tests
Trypanosoma cruzi
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

439. Product name placement, size, and prominence in promotional labeling and advertisements

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2017

Subject(s):

Advertising -- standards
Prescription Drugs -- standards
Product Labeling -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

440. Systemic antibacterial and antifungal drugs: susceptibility test interpretive criteria labeling for NDAs and ANDAs

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2017

Subject(s):

Anti-Bacterial Agents
Antifungal Agents
Investigational New Drug Application
Microbial Sensitivity Tests
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

441. Unique device identification: policy regarding compliance dates for class I and unclassified devices : immediately in effect guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, January 16, 2018

Subject(s):

Equipment and Supplies -- classification
Product Labeling -- standards
Product Packaging -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

442. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2017

Subject(s):

Abuse-Deterrent Formulations -- standards
Analgesics, Opioid -- administration & dosage
Drugs, Generic
Investigational New Drug Application
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

443. Improving oral health: promise and prospects

Author(s):

Ryan, Jennifer (Jennifer M.)

Publication:

Washington, D.C. : National Health Policy Forum, [2003]

Subject(s):

Dental Care -- economics
Dental Care
Health Policy
Health Services Accessibility -- economics
Health Workforce
Medical Assistance
Poverty
United States

444. WIC reauthorization: opportunities for improving the nutritional status of women, infants, and children

Author(s):

Fox, Harriette.

Publication:

Washington, D.C. : George Washington University, National Health Policy Forum, [2003]

Subject(s):

Child Welfare -- legislation & jurisprudence
Eligibility Determination -- economics
Infant Welfare -- legislation & jurisprudence
Maternal Welfare -- legislation & jurisprudence
Nutrition Policy -- legislation & jurisprudence
Public Assistance -- economics
United States
Special Supplemental Nutrition Program for Women, Infants, and Children (U.S.)

445. Bridging silos: Part I : linkages among the DI, SSI, Medicare, and Medicaid programs

Author(s):

Matherlee, Karen.

Publication:

Washington, D.C. : National Health Policy Forum, [2003]

Subject(s):

Insurance, Disability -- economics
Medicaid -- economics
Medicare -- economics
Public Assistance -- economics
United States

446. The economics of quality: changing incentives in Cincinnati : site visit report

Publication:

Washington, D.C. : National Health Policy Forum, [2004]

Subject(s):

Delivery of Health Care -- economics
Delivery of Health Care -- organization & administration
Quality of Health Care -- economics
Quality of Health Care -- organization & administration
Ohio

447. Tick-tock: preparing for the next influenza pandemic

Author(s):

Salinsky, Eileen.

Publication:

Washington, D.C. : National Health Policy Forum, [2004]

Subject(s):

Influenza, Human -- prevention & control
United States

448. The fundamentals of community health centers

Author(s):

Taylor, Jessamy.

Publication:

Washington, D.C. : National Health Policy Forum, [2004]

Subject(s):

Community Health Centers -- organization & administration
United States

449. The electronic health record in practice: why, how, and what next? : Site visit report

Publication:

Washington, D.C. : George Washington University, 2006

Subject(s):

Medical Records Systems, Computerized -- statistics & numerical data
United States
United States. Department of Veterans Affairs

450. Medicare's use of risk adjustment

Publication:

Washington, D.C. : George Washington University, [2007]

Subject(s):

Insurance, Health, Reimbursement
Medicare -- economics
Prospective Payment System
Risk Adjustment
United States

451. Health benefits in retirement: set for extinction?

Publication:

Washington, D.C. : National Health Policy Forum, [2006]

Subject(s):

Health Benefit Plans, Employee -- economics
Retirement -- economics
United States

452. The State Health Insurance Assistance Program (SHIP): the basics

Publication:

Washington, D.C. : George Washington University, [2010]

Subject(s):

Community-Institutional Relations
Inservice Training -- organization & administration
Insurance, Health
Medicare
Patient Education as Topic
United States
Centers for Medicare & Medicaid Services (U.S.)

453. Health care price transparency and price competition

Publication:

Washington, D.C. : George Washington University, [2007]

Subject(s):

Disclosure
Economic Competition
Health Care Costs
United States
Centers for Medicare & Medicaid Services (U.S.)
Medicare Payment Advisory Commission (U.S.)

454. Shaping Medicaid and SCHIP through waivers: the fundamentals

Publication:

Washington, D.C. : George Washington University, [2008]

Subject(s):

Child Health Services -- economics
Child Health Services -- legislation & jurisprudence
Medicaid -- economics
Medicaid -- legislation & jurisprudence
United States
State Children's Health Insurance Program (U.S.)

455. Classification of products as drugs and devices & additional product classification issues: final guidance : guidance for industry and FDA staff

Publication:

Silver Spring, MD : Office of Combination Products, Food and Drug Administration, September 2017

Subject(s):

Biological Products -- classification
Classification -- methods
Equipment and Supplies -- classification
Pharmaceutical Preparations -- classification
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

456. Compliance policy for required warning statements on small-packaged cigars

Publication:

Silver Spring, MD : Center for Tobacco Products, Food and Drug Administration, September 2017

Subject(s):

Product Labeling -- standards
Product Packaging -- standards
Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

457. Center for Devices and Radiological Health appeals processes: questions and answers about 517A : guidance for industry and Food and Drug Administration staff

Publication:

[Silver Spring, Maryland] : Center for Devices and Radiological Health, September 29, 2017

Subject(s):

Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

458. Developing and responding to deficiencies in accordance with the least burdensome provisions: guidance for industry and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Devices and Radiological Health, September 29, 2017

Subject(s):

Device Approval -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

459. Evaluating drug effects on the ability to operate a motor vehicle

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2017

Subject(s):

Automobile Driving
Driving Under the Influence
Drug Evaluation -- standards
Psychotropic Drugs -- adverse effects
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

460. Recurrent herpes labialis: developing drugs for treatment and prevention

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2017

Subject(s):

Antiviral Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation, Preclinical
Drugs, Investigational -- therapeutic use
Herpes Labialis -- drug therapy
Herpes Labialis -- prevention & control
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

461. M4 organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, October 2017

Subject(s):

Documentation -- standards
Drug Approval
Canada
Europe
Japan
Switzerland
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

462. Chronic hepatitis C virus infection: developing direct-acting antiviral drugs for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, November 2017

Subject(s):

Antiviral Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Hepatitis C, Chronic -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

463. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017

Subject(s):

Blood Donors
Donor Selection -- standards
Hepacivirus
Hepatitis C -- blood
HIV Infections -- blood
HIV-1
RNA, Viral -- blood
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

464. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2017

Subject(s):

Biological Availability
Drugs, Investigational -- pharmacokinetics
Investigational New Drug Application
Therapeutic Equivalency
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

465. Mixing, diluting, or repackaging biological products outside the scope of an approved biologics license application

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, January 2018

Subject(s):

Biological Products
Drug Approval
Drug Packaging
Prescription Drugs
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

466. Use of x-rays for incorrect needle counts

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2004

Subject(s):

Foreign Bodies -- diagnostic imaging
Needles
Radiographic Image Enhancement
Radiography
United States

467. Strategies for avoiding problems with the use of pneumatic tourniquets

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010

Subject(s):

Safety Management -- methods
Tourniquets -- adverse effects
United States

468. Patient identification

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2004

Subject(s):

Medical Errors -- prevention & control
Patient Identification Systems -- methods
Safety Management -- methods
United States

469. Use of checklists in complex environments

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2004

Subject(s):

Checklist
Organizational Culture
Safety Management
United States

470. Demonstrating return on investment for infection prevention and control

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010

Subject(s):

Cost-Benefit Analysis
Cross Infection -- economics
Cross Infection -- prevention & control
Infection Control -- economics
United States

471. Retail clinics: six state approaches to regulation and licensing

Publication:

[Oakland, Calif.] : California HealthCare Foundation, [2009]

Subject(s):

Ambulatory Care Facilities -- organization & administration
Commerce -- legislation & jurisprudence
Health Services Accessibility -- organization & administration
United States

472. Safeguarding the storage of drug products

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010

Subject(s):

Drug Storage -- methods
Medication Errors -- prevention & control
Pharmacy Service, Hospital
Risk Management
Pennsylvania
United States

473. Indications for and management of inferior vena cava filters

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2011

Subject(s):

Patient Care Management
Pulmonary Embolism -- prevention & control
Vena Cava Filters -- statistics & numerical data
Venous Thrombosis -- prevention & control
United States

474. Data snapshot: falls reported by behavioral health hospitals

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010

Subject(s):

Accidental Falls -- statistics & numerical data
Drug-Related Side Effects and Adverse Reactions
United States

475. Diagnostic error in acute care

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010

Subject(s):

Delayed Diagnosis -- adverse effects
Delayed Diagnosis -- prevention & control
Delayed Diagnosis -- psychology
Diagnostic Errors -- adverse effects
Diagnostic Errors -- prevention & control
Diagnostic Errors -- psychology
Diagnostic Techniques and Procedures -- psychology
Physicians -- psychology
United States

476. Managing patients with limited English proficiency

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2011

Subject(s):

Communication Barriers
Cultural Competency
Health Services Accessibility
Language
Needs Assessment
Patient Care Management
Professional-Patient Relations
United States

477. Quarterly update: the evidence base for best practices for preventing wrong-site surgery

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010

Subject(s):

Clinical Protocols
Evidence-Based Medicine
Medical Errors -- prevention & control
Process Assessment, Health Care
Surgical Procedures, Operative -- adverse effects
Systems Analysis
Pennsylvania
United States

478. Data snapshot: errors involving methotrexate

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2011

Subject(s):

Antimetabolites, Antineoplastic -- administration & dosage
Antimetabolites, Antineoplastic -- adverse effects
Medication Errors
Methotrexate -- administration & dosage
Methotrexate -- adverse effects
United States

479. Time-out wrong-site surgery update

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2011

Subject(s):

Medical Errors -- prevention & control
Patient Care Team -- organization & administration
Risk Reduction Behavior
Surgical Procedures, Operative
Time Factors
United States

480. Neuromuscular blocking agents: reducing associated wrong-drug errors

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Medication Errors -- prevention & control
Neuromuscular Blocking Agents -- administration & dosage
Neuromuscular Blocking Agents -- adverse effects
Neuromuscular Depolarizing Agents -- administration & dosage
Neuromuscular Depolarizing Agents -- adverse effects
Risk Management -- methods
United States

481. Quarterly update on the Preventing Wrong-Site Surgery Project: improving, but still room for perfection

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Medical Errors -- prevention & control
Surgical Procedures, Operative -- statistics & numerical data
United States

482. Medication errors in labor and delivery: reducing maternal and fetal harm

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Labor, Obstetric -- drug effects
Medication Errors -- adverse effects
Medication Errors -- prevention & control
Risk Management -- methods
Pennsylvania
United States

483. Improvement in preventing wrong-site surgery!: traction or transient?

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Medical Errors -- prevention & control
Patient Identification Systems -- methods
Surgical Procedures, Operative -- methods
United States

484. Using administrative data from Pennsylvania hospitals to monitor patient safety

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Patient Care
Quality Indicators, Health Care -- statistics & numerical data
Safety Management -- methods
Pennsylvania
United States

485. An update on the "epi"demic: events involving EPINEPHrine

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Epinephrine -- administration & dosage
Epinephrine -- adverse effects
Medication Errors -- prevention & control
United States

486. Neonatal complications: recognition and prompt treatment of shoulder dystocia

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Birth Injuries -- etiology
Dystocia -- therapy
Fetal Monitoring -- methods
Obstetric Labor Complications -- prevention & control
United States

487. Medication errors: significance of accurate patient weights

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Body Weight
Drug Dosage Calculations
Medication Errors -- prevention & control
Pharmaceutical Preparations -- administration & dosage
United States

488. Data snapshot: iatrogenic burn injuries

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Burns -- epidemiology
Burns -- etiology
Iatrogenic Disease -- epidemiology
United States

489. Safe intrahospital transport of the non-ICU patient using standardized handoff communication

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Communication
Continuity of Patient Care -- standards
Interprofessional Relations
Patient Transfer
Process Assessment, Health Care -- methods
Safety Management
Transportation of Patients -- standards
United States

490. Successful reduction of healthcare-associated MRSA infection rates

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Cross Infection -- epidemiology
Cross Infection -- prevention & control
Infection Control -- methods
Staphylococcal Infections -- epidemiology
Staphylococcal Infections -- prevention & control
United States

491. Uterine perforation associated with minimally invasive gynecologic procedures

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Gynecologic Surgical Procedures -- adverse effects
Minimally Invasive Surgical Procedures -- adverse effects
Uterine Perforation -- etiology
United States

492. Safety in the MR environment: ferromagnetic projectile objects in the MRI scanner room

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009

Subject(s):

Accident Prevention
Accidents
Equipment Safety -- standards
Magnetic Resonance Imaging -- adverse effects
Magnetics
United States

493. Preventing the retention of foreign objects during interventional radiology procedures

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008

Subject(s):

Foreign Bodies -- prevention & control
Medical Errors -- prevention & control
Radiology, Interventional
Pennsylvania
United States

494. Medication assessment: one determinant of falls risk

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008

Subject(s):

Accidental Falls -- statistics & numerical data
Drug Monitoring
Drug-Related Side Effects and Adverse Reactions
Medication Therapy Management
Risk Assessment -- methods
Pennsylvania
United States

495. Medication errors with the dosing of insulin: problems across the continuum

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2010

Subject(s):

Hyperglycemia -- drug therapy
Insulin -- administration & dosage
Medication Errors -- prevention & control
Pennsylvania
United States

496. Surgical site markers: putting your mark on patient safety

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008

Subject(s):

Cross Infection -- prevention & control
Equipment Contamination -- prevention & control
Equipment Reuse
Ink
Medical Errors -- prevention & control
Preoperative Care
Surgical Procedures, Operative
Pennsylvania
United States

497. Quarterly update on the Preventing Wrong-Site Surgery Project

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008

Subject(s):

Medical Errors -- prevention & control
Preoperative Care
Surgical Procedures, Operative
Pennsylvania
United States

498. Quarterly update on the Preventing Wrong-Site Surgery Project

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008

Subject(s):

Medical Errors -- prevention & control
Preoperative Care
Surgical Procedures, Operative
Pennsylvania
United States

499. Prevention of inadvertent perioperative hypothermia

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2008

Subject(s):

Body Temperature Regulation
Hypothermia -- prevention & control
Intraoperative Complications -- prevention & control
Postoperative Care
Postoperative Complications -- prevention & control
Pennsylvania
United States

500. Saves, system improvements, and safety II

Publication:

[Harrisburg, Pennsylvania] : Pennsylvania Patient Safety Authority, September 2016

Subject(s):

Medical Errors -- prevention & control
Preoperative Period
Systems Analysis
Pennsylvania
United States